source
- ObesityWeek 2026 to showcase amylin pathway and emerging weight-loss mechanismsObesityWeek 2026 starts Saturday in Washington, DC, gathering weight-loss experts and biopharma companies with metabolic assets. The meeting will highlight the amylin pathway and other emerging me…
- Gubra appoints ex-HHS official Brett Giroir as co-CEO after sudden exit of Markus RohrwildGubra, the Danish obesity partner of AbbVie and Boehringer Ingelheim, announced a leadership change following the abrupt departure of its CEO, Markus Rohrwild. The company will operate under a co…